Skip to content

Envoy Medical COCH Finished goods

Finished goods at other companies

Cabot Corporation logo
Cabot CorporationCBT
$310M-6.9%
SOL
SOLSSOLS
$409M
Aebi Schmidt Holding AG Common Stock logo
Aebi Schmidt Holding AG Common StockAEBI
$123.16M+4.5%
Envista Holdings Corporation logo
Envista Holdings CorporationNVST
$222.3M+11.9%
Vontier logo
VontierVNT
$145.4M-4.3%
Atmus Filtration Technologies logo
Atmus Filtration TechnologiesATMU
$225.7M+10.8%

Other financials

Income statement

See full
Revenue$39.0K-15.2%
Gross profit-$274.0K-52.2%
Operating income-$6.0M-16.7%
Net income-$4.4M+12.9%
EPS (diluted)-$0.08+72.4%

Balance sheet

See full
Cash & equivalents$25.3M+376%
Total debt$919.0K-2.8%
Total equity$10.2M+142%
Total assets$29.8M+187%

Cash flow

See full
Operating cash flow-$6.1M-62.7%
CapEx$172.0K
Free cash flow-$5.9M-28.5%

Valuation

See full
Market cap$61M+83.5%
P/S260.7×+111×

Profitability

See full
Gross margin-310.7%+31.6pp
Operating margin-9,881.2%+805pp
Net margin-9,875.6%+771pp
FCF margin-7,626.6%-652pp

Returns & leverage

See full
Return on equity328.7%
Debt / equity0.1×
Current ratio2.3×+1.2×

Where this comes from

Reported directly by Envoy Medical in its filing.

Tagged under the XBRL concept us-gaap:InventoryFinishedGoods.

The official record: Envoy Medical’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about Envoy Medical's finished goods.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Envoy Medical's finished goods?
Envoy Medical (COCH) reported finished goods of $196K in Q1 2026.
How has Envoy Medical's finished goods changed year-over-year?
Envoy Medical's finished goods increased by 19.5% year-over-year, from $164K to $196K.
What is the long-term trend for Envoy Medical's finished goods?
Over 3 years (2022 to 2025), Envoy Medical's finished goods has grown at a 17.4% compound annual growth rate (CAGR), from $121K to $196K.
What does finished goods mean?
Completed products ready for sale, valued at the lower of cost or net realizable value.